1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. California >
  6. BioMarin Pharmaceutical

BioMarin Pharmaceutical - M&A Summary and Business Overview

Life ScienceCompany

BioMarin Pharmaceutical M&A Summary

BioMarin Pharmaceutical has acquired 3 companies, including 1 in the last 5 years.

BioMarin Pharmaceutical’s largest acquisition to date was in 2014, when it acquired Prosensa for $680M. BioMarin Pharmaceutical has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (67%) and healthcare services (34%).

BioMarin Pharmaceutical Business Overview

Where is BioMarin Pharmaceutical headquartered?

BioMarin Pharmaceutical is headquartered in San Rafael, California.

What is BioMarin Pharmaceutical’s revenue?

BioMarin Pharmaceutical disclosed revenue of 2,854M USD for 2024 and 2,419M USD for 2023.

How many employees does BioMarin Pharmaceutical have?

BioMarin Pharmaceutical has 3,040 employees.

What sector is BioMarin Pharmaceutical in?

BioMarin Pharmaceutical is a life science company.

When was BioMarin Pharmaceutical founded?

BioMarin Pharmaceutical was founded in 1996.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Advisors 2

BioMarin Pharmaceutical

BioMarin Pharmaceutical, Inc.

770 Lindaro Street,
San Rafael, California 94901
United States,
(415) 506-6700
www.biomarin.com

BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. BioMarin Pharmaceutical was founded in 1996 and is based in San Rafael, California.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # 2 - - - - 1 3
vol $690M $270M $960M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Inozyme Pharma, Inc. 2025-05-16 270M USD Add-on Acquisition
Boston, Massachusetts · www.inozyme.com
Prosensa 2014-11-24 680M USD Add-on Acquisition
Leiden, Netherlands · www.prosensa.eu
Zacharon Pharmaceuticals, Inc. 2013-01-07 10M USD Add-on Acquisition
San Diego, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (67%) 950M (99%) - -
Healthcare Services 1 (33%) 10M (1%) - -
Total 3 $960M - -

By Geo

State/Country Buy Value Sell Value
United States 2 280M - -
  Massachusetts 1 270M - -
  California 1 10M - -
Netherlands 1 680M - -
Domestic 2 (67%) 280M (29%) - -
Cross-border 1 (33%) 680M (71%) - -
Total 3 $960M - -

Top M&A Advisors

Financial Deals
Goldman Sachs
 1
Legal Deals
Cooley
 1

Deal Values

buy # Total
$100M to $1B 2 $950M
< $100M 1 $10M
TOTAL $960M
Largest Prosensa
$680M (2014-11-24)

Company Summary

SECTOR

Life Science

Revenue

2,854   18% 2024
2,419   16% 2023
2,096   14% 2022
1,846   1% 2021
1,860   10% 2020
1,704   15% 2019
1,491   14% 2018
1,314   18% 2017
1,117   26% 2016
890   19% 2015
751   38% 2014
548   10% 2013
500   2012
(millions of USD) Show More Show Less

Employees

3,040

Established

1996

Public

NASDAQ: BMRN

 Subscribe to unlock this and 214,646
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for BioMarin Pharmaceutical

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal